Back to search

Germany· DE-A57-81fcda2206461c27

Echinacea E Planta Tota

A medicinal product containing echinacea pallida e planta tota ferm 33c dil. d2 (hab, vs. 33c), registered in Germany by Wala Heilmittel Gmbh.

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedEchinacea E Planta TotaATC—REGISTER NO.DE-A57-81fcda2206461c…PACKS LISTED0CHECKEDSeptember 30, 2026

The record

At a glance

EMA Article 57 (European Union)
Active substance
Echinacea Pallida E Planta Tota Ferm 33c Dil. D2 (Hab, Vs. 33c)
Manufacturer
Wala Heilmittel Gmbh
Country
Germany (DE)
ATC code
—
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b086d79e-82a6-4c88-8652-881d4f61603e
GET /v1/drugs/b086d79e-82a6-4c88-8652-881d4f61603e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Subcutaneous Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Echinacea Pallida E Planta Tota Ferm 33c Dil. D2 (Hab, Vs. 33c)",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about echinacea pallida e planta tota ferm 33c dil. d2 (hab, vs. 33c).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.